Deleted Journal,
Journal Year:
2023,
Volume and Issue:
2, P. 262 - 262
Published: Dec. 30, 2023
Heart
failure
(HF)
after
a
myocardial
infarction
(MI)
is
one
of
the
most
frequent
complications
and
with
highest
mortality
rate
in
population.
Given
this,
importance
finding
appropriate
biomarkers
for
diagnosis,
prognosis
treatment
this
condition.
The
review
was
carried
out
under
an
analytical
approach,
using
PRISMA
statement
as
methodology;
documents
were
retrieved
through
Scopus,
ScienceDirect
PubMed
databases,
where
20
articles
that
met
certain
inclusion
criteria
recognized.
In
conclusion,
it
explained
use
standard
such
B-type
natriuretic
peptide
(BNP)
non-terminal
pro-BNP
clinical
practice
have
limitations,
especially
due
to
their
low
specificity
HF
post-MI
complication.
Therefore,
currently,
reflect
alteration
cardiac
integrity,
injury
necrosis,
inflammatory
biomarkers,
fibrosis,
biomechanical
stress,
other
types
non-coding
RNAs
are
being
investigated
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4273 - 4273
Published: Dec. 11, 2024
Myocardial
infarction
(MI)
can
range
from
mild
to
severe
cardiovascular
events
and
typically
develops
through
complex
interactions
between
genetic
lifestyle
factors.
We
aimed
understand
the
predisposition
associated
with
MI
correlation,
colocalization
analysis,
cells'
gene
expression
values
develop
more
effective
prevention
treatment
strategies
reduce
its
burden.
A
polygenic
risk
score
(PRS)
was
employed
estimate
for
analyze
dietary
PRS
that
affect
in
adults
over
45
years
(
Ten
significant
variants
were
related
cardiac,
immune,
brain
functions.
high
a
threefold
increase
(OR:
3.074,
95%
CI:
2.354-4.014,
This
study
identified
novel
patterns
risk,
influenced
by
their
interaction
fat
alcohol
intake,
smoking
status.
Our
findings
provide
insights
developing
personalized
targeting
this
clinical
presentation
of
MI.
Deleted Journal,
Journal Year:
2023,
Volume and Issue:
2, P. 262 - 262
Published: Dec. 30, 2023
Heart
failure
(HF)
after
a
myocardial
infarction
(MI)
is
one
of
the
most
frequent
complications
and
with
highest
mortality
rate
in
population.
Given
this,
importance
finding
appropriate
biomarkers
for
diagnosis,
prognosis
treatment
this
condition.
The
review
was
carried
out
under
an
analytical
approach,
using
PRISMA
statement
as
methodology;
documents
were
retrieved
through
Scopus,
ScienceDirect
PubMed
databases,
where
20
articles
that
met
certain
inclusion
criteria
recognized.
In
conclusion,
it
explained
use
standard
such
B-type
natriuretic
peptide
(BNP)
non-terminal
pro-BNP
clinical
practice
have
limitations,
especially
due
to
their
low
specificity
HF
post-MI
complication.
Therefore,
currently,
reflect
alteration
cardiac
integrity,
injury
necrosis,
inflammatory
biomarkers,
fibrosis,
biomechanical
stress,
other
types
non-coding
RNAs
are
being
investigated
